Все публикации

Using Biomarkers to Assess the Risk of Comorbidities in Atopic Dermatitis | Christian Vestergaard

Using Biomarkers to Inform the Treatment of Atopic Dermatitis | Marjolein de Bruin-Weller, MD, PhD

Using Biomarkers to Assess the Risk of Comorbidities in Psoriasis | Catherine Smith, MD | UK

Reduced Filaggrin Expression Reduces ERK Signaling and Disrupts Desmosomes in Atopic Eczema

The Effect of Age on the Severity of Psoriasis | Shir Azrielant, MD | United Kingdom

Protective Effects of Systemic Therapies for Psoriasis Against Thrombotic Events | Alison Treichel,

Genetic and Ethnic Differences in Psoriasis and Atopic Dermatitis | Sara Brown, MBChB, MD | UK

Panel Discussion: From Comparative Pathogenesis to Biomarker-guided Treatments in Psoriasis &Eczema

Immune Phenotype Switching | Michel Gilliet, MD | Switzerland

Comparative Whole Metagenome Sequencing Analysis in Psoriasis Capitis Patients & Healthy Individuals

Integrated Practice Units – An Example from Rheumatology | Fiona Koster | Netherlands

Advantages of the Integrated Practice Unit | Marcia Makdisse, MD, MSc, PhD, MBA, MSHCT | Brazil

IPC Symposia Committee - 2024

The Epidemiology of Psoriasis | Juul van den Reek, MD, PhD | Netherlands

The Full Cycle of Psoriasis Care in 2024: Value or Volume? | 2024 Global Webinar Series

What Exists in Dermatology and Psoriasis? | Deepak Balak, MD, PhD, MSc | Netherlands

Value-Based Healthcare – A Primer | Willem Jan Bos, MD, PhD | Netherlands

IPC Regional Development Task Force - 2024

IPC Research Committee - 2024

Granzyme K Promotes IL-23 Secretion & Keratinocyte Proliferation in Psoriasis | Katlyn Richardson

Dual Role of Dermal Adipogenesis in Regulating Neutrophil Activation & Regression | Ling-Juan Zhang

Periodontitis as a Risk Factor for Psoriasis | Rudolf E. Schopf, MD | Germany

Statistical Genomics & Multi-omic Approaches in Advancing Genetic Research for Psoriasis | Alex Tsoi

The Microbiome and Psoriasis | Wilson Liao, MD | United States